FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Ramucirumab 10 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Ramucirumab 10 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Venetoclax 10 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Venetoclax 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Venetoclax 50 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Venetoclax 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Venetoclax 100 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Venetoclax 100 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely avelumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely avelumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ivosidenib 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely ivosidenib 250 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely pembrolizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely pembrolizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing only radium-223 (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Radium-223 only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely teduglutide 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely teduglutide 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing only midazolam in nasal dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing only alpelisib (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Alpelisib only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Alpelisib 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Alpelisib 50 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely alpelisib 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely alpelisib 150 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely alpelisib 200 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely alpelisib 200 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only polatuzumab vedotin (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Polatuzumab vedotin only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Bremelanotide only product Count of base of active ingredient False un Inferred relationship Some
    Bremelanotide only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing only onabotulinumtoxinA (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    OnabotulinumtoxinA only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely onabotulinumtoxinA 200 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely onabotulinumtoxinA 200 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely onabotulinumtoxinA 100 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely onabotulinumtoxinA 100 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only selinexor (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Selinexor only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Gadobutrol only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing only nitrous oxide in pulmonary dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Glucagon only product in nasal dose form Count of base of active ingredient False un Inferred relationship Some
    Glucose 50 mg/mL and sodium chloride 9 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Glucose 50 mg/mL and sodium chloride 9 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 2
    Apremilast only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely apremilast 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely apremilast 20 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Apremilast 10 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Apremilast 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely apremilast 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely apremilast 30 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing only darolutamide (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Product containing only darolutamide in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen Has presentation strength denominator value False un Inferred relationship Some 1
    Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen Count of base of active ingredient False un Inferred relationship Some
    Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen Has presentation strength denominator value False un Inferred relationship Some 1
    Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen Count of base of active ingredient False un Inferred relationship Some
    Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen Count of base of active ingredient False un Inferred relationship Some
    Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen Has presentation strength denominator value False un Inferred relationship Some 1
    Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen Count of base of active ingredient False un Inferred relationship Some
    Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen Has presentation strength denominator value False un Inferred relationship Some 1
    Pexidartinib only product Count of base of active ingredient False un Inferred relationship Some
    Product containing only pexidartinib in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely albumin human 250 milligram/1 milliliter conventional release solution for infusion (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely albumin human 250 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing only albumin human (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Albumin human only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Albumin human 50 mg/mL solution for infusion Has concentration strength denominator value False un Inferred relationship Some 1
    Albumin human 50 mg/mL solution for infusion Count of base of active ingredient False un Inferred relationship Some
    Albumin human 45 mg/mL solution for infusion Count of base of active ingredient False un Inferred relationship Some
    Albumin human 45 mg/mL solution for infusion Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely albumin human 200 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely albumin human 200 milligram/1 milliliter conventional release solution for infusion (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Pretomanid only product Count of base of active ingredient False un Inferred relationship Some
    Product containing only pretomanid in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Pitolisant only product Count of base of active ingredient False un Inferred relationship Some
    Product containing only pitolisant in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing only entrectinib (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Product containing only entrectinib in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Fedratinib only product Count of base of active ingredient False un Inferred relationship Some
    Product containing only fedratinib in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Tegaserod only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing only liraglutide in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some

    Start Previous Page 206 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start